Copyright
©The Author(s) 2016.
World J Diabetes. Dec 15, 2016; 7(20): 615-620
Published online Dec 15, 2016. doi: 10.4239/wjd.v7.i20.615
Published online Dec 15, 2016. doi: 10.4239/wjd.v7.i20.615
Table 2 Clinical characteristics of diabetes mellitus type 2 patients
| Baseline characteristics | DM2 patients with cognitive impairment (n = 19) | DM2 patients without cognitive impairment (n = 18) | P |
| Age (yr) | 50.57 ± 5.90 | 54.05 ± 3.63 | 0.06 |
| Duration of DM2 (yr) | 14.31 ± 6.22 | 9.05 ± 4.64 | 0.007 |
| BDNF (ng/mL) | 31.55 ± 10.24 | 43.78 ± 9.05 | 0.005 |
| Glucose (mg/dL) | 177 ± 64.91 | 138 ± 43.90 | 0.07 |
| Glycated hemoglobin (HBA1c) (%) | 8.36 ± 1.52 | 7.33 ± 1.42 | 0.02 |
| Minimental state examination | 20.26 ± 2.15 | 25.44 ± 1.50 | 0.0001 |
- Citation: Murillo Ortíz B, Ramírez Emiliano J, Ramos-Rodríguez E, Martínez-Garza S, Macías-Cervantes H, Solorio-Meza S, Pereyra-Nobara TA. Brain-derived neurotrophic factor plasma levels and premature cognitive impairment/dementia in type 2 diabetes. World J Diabetes 2016; 7(20): 615-620
- URL: https://www.wjgnet.com/1948-9358/full/v7/i20/615.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i20.615